Alacrita

Anthony leverages 12 years of building and managing a biotechnology company together with over 12 years as a management consultant to the chemical, pharma and biotechnology industries.

His experience includes due diligence, technology/market appraisal, business planning, licensing, raising venture capital finance, and M&A.

Prior to forming Alacrita, Anthony was CEO of Onyvax, a company he co-founded in 1997, raising over £35 million from blue chip life science investors including 3i and S.R. One.

Before Onyvax, he spent 10 years as a management consultant, specialising in the pharmaceutical and biotechnology industries. He consulted to Big Pharma and biotech, and also produced Expert Reports for five IPOs:

• At Arthur D. Little, he was appointed a European Director, responsible for the London-based pharmaceutical practice
• At The Wilkerson Group, he had responsibility for its UK consulting practice

Anthony Walker holds an Honours degree in Natural Sciences and a Ph.D. in Biochemistry from the University of Cambridge.